| NTP ICE skin irritation |
Breakthrough Time |
16.15 |
min |
- |
Dermal |
- |
In Vitro; Corrositex |
sheet=Data_invitro; excel_row=1164; Record_ID=skin_irritation_invitro_166; Data_Type=In Vitro; Formulation_ID=MIX804; Formulation_Name=Sulfuric acid/ Sodium dodecyl sulfate; Percent_Active_Ingredient=10; Mixture=Mixture; DTXSID=DTXSID1026031; Assay=Corrositex; Endpoint=Breakthrough Time; Response=16.15; Response_Unit=min; Reference=ICCVAM 1999; Not available; ntp.niehs.nih.gov/iccvam/docs/dermal_docs/corprrep.pdf; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Breakthrough Time |
32.1 |
min |
- |
Dermal |
- |
In Vitro; Corrositex |
sheet=Data_invitro; excel_row=1163; Record_ID=skin_irritation_invitro_165; Data_Type=In Vitro; Formulation_ID=MIX803; Formulation_Name=Sodium hydroxide/ Sodium dodecyl sulfate(1:10); Percent_Active_Ingredient=90; Mixture=Mixture; DTXSID=DTXSID1026031; Assay=Corrositex; Endpoint=Breakthrough Time; Response=32.1; Response_Unit=min; Reference=ICCVAM 1999; Not available; ntp.niehs.nih.gov/iccvam/docs/dermal_docs/corprrep.pdf; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Breakthrough Time |
140 |
min |
- |
Dermal |
- |
In Vitro; Corrositex |
sheet=Data_invitro; excel_row=1032; Record_ID=skin_irritation_invitro_73; Data_Type=In Vitro; Formulation_ID=MIX787; Formulation_Name=Empicol LZPV/C; Mixture=Mixture; DTXSID=DTXSID1026031; Assay=Corrositex; Endpoint=Breakthrough Time; Response=140; Response_Unit=min; Reference=Botham et al. 1995; Not available; 10.1177/026119299502300207; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Breakthrough Time |
240 |
min |
- |
Dermal |
- |
In Vitro; Corrositex |
sheet=Data_invitro; excel_row=1031; Record_ID=skin_irritation_invitro_74; Data_Type=In Vitro; Formulation_ID=MIX787; Formulation_Name=Empicol LZPV/C; Mixture=Mixture; DTXSID=DTXSID1026031; Assay=Corrositex; Endpoint=Breakthrough Time; Response=240; Response_Unit=min; Reference=Botham et al. 1995; Not available; 10.1177/026119299502300207; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
ET50 |
37.9 |
min |
- |
Dermal |
- |
In Vitro; EpiDerm Irritation |
sheet=Data_invitro; excel_row=1294; Record_ID=skin_irritation_invitro_1517; Data_Type=In Vitro; Formulation_Name=SLS (20%); Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiDerm Irritation; Endpoint=ET50; Response=37.9; Response_Unit=min; Reference=Fentem et al. 2001; 11259870; 10.1016/s0887-2333(01)00002-9; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
ET50 |
42.9 |
min |
- |
Dermal |
- |
In Vitro; EpiDerm Irritation |
sheet=Data_invitro; excel_row=1295; Record_ID=skin_irritation_invitro_1519; Data_Type=In Vitro; Formulation_Name=SLS (20%); Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiDerm Irritation; Endpoint=ET50; Response=42.9; Response_Unit=min; Reference=Fentem et al. 2001; 11259870; 10.1016/s0887-2333(01)00002-9; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
ET50 |
44.9 |
min |
- |
Dermal |
- |
In Vitro; EpiDerm Irritation |
sheet=Data_invitro; excel_row=1167; Record_ID=skin_irritation_invitro_1520; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (50%); Concentration=50; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiDerm Irritation; Endpoint=ET50; Response=44.9; Response_Unit=min; Reference=Fentem et al. 2001; 11259870; 10.1016/s0887-2333(01)00002-9; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
ET50 |
50.2 |
min |
- |
Dermal |
- |
In Vitro; EpiDerm Irritation |
sheet=Data_invitro; excel_row=1168; Record_ID=skin_irritation_invitro_1521; Data_Type=In Vitro; Formulation_Name=SLS (20%); Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiDerm Irritation; Endpoint=ET50; Response=50.2; Response_Unit=min; Reference=Fentem et al. 2001; 11259870; 10.1016/s0887-2333(01)00002-9; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
ET50 |
51.9 |
min |
- |
Dermal |
- |
In Vitro; EpiDerm Irritation |
sheet=Data_invitro; excel_row=1169; Record_ID=skin_irritation_invitro_1523; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (50%); Concentration=50; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiDerm Irritation; Endpoint=ET50; Response=51.9; Response_Unit=min; Reference=Fentem et al. 2001; 11259870; 10.1016/s0887-2333(01)00002-9; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
ET50 |
76.8 |
min |
- |
Dermal |
- |
In Vitro; EpiDerm Irritation |
sheet=Data_invitro; excel_row=1170; Record_ID=skin_irritation_invitro_1524; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (50%); Concentration=50; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiDerm Irritation; Endpoint=ET50; Response=76.8; Response_Unit=min; Reference=Fentem et al. 2001; 11259870; 10.1016/s0887-2333(01)00002-9; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
ET50 |
93.5 |
min |
- |
Dermal |
- |
In Vitro; EpiDerm Irritation |
sheet=Data_invitro; excel_row=1293; Record_ID=skin_irritation_invitro_1526; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (50%); Concentration=50; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiDerm Irritation; Endpoint=ET50; Response=93.5; Response_Unit=min; Reference=Fentem et al. 2001; 11259870; 10.1016/s0887-2333(01)00002-9; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
ET50 |
95.6 |
min |
- |
Dermal |
- |
In Vitro; EpiDerm Irritation |
sheet=Data_invitro; excel_row=1034; Record_ID=skin_irritation_invitro_1528; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (50%); Concentration=50; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiDerm Irritation; Endpoint=ET50; Response=95.6; Response_Unit=min; Reference=Fentem et al. 2001; 11259870; 10.1016/s0887-2333(01)00002-9; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
ET50 |
108 |
min |
- |
Dermal |
- |
In Vitro; EpiDerm Irritation |
sheet=Data_invitro; excel_row=1035; Record_ID=skin_irritation_invitro_1530; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (50%); Concentration=50; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiDerm Irritation; Endpoint=ET50; Response=108; Response_Unit=min; Reference=Fentem et al. 2001; 11259870; 10.1016/s0887-2333(01)00002-9; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
ET50 |
116 |
min |
- |
Dermal |
- |
In Vitro; EpiDerm Irritation |
sheet=Data_invitro; excel_row=1036; Record_ID=skin_irritation_invitro_1532; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (50%); Concentration=50; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiDerm Irritation; Endpoint=ET50; Response=116; Response_Unit=min; Reference=Fentem et al. 2001; 11259870; 10.1016/s0887-2333(01)00002-9; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
ET50 |
126 |
min |
- |
Dermal |
- |
In Vitro; EpiDerm Irritation |
sheet=Data_invitro; excel_row=1037; Record_ID=skin_irritation_invitro_1534; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (50%); Concentration=50; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiDerm Irritation; Endpoint=ET50; Response=126; Response_Unit=min; Reference=Fentem et al. 2001; 11259870; 10.1016/s0887-2333(01)00002-9; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
ET50 |
139 |
min |
- |
Dermal |
- |
In Vitro; EpiDerm Irritation |
sheet=Data_invitro; excel_row=1038; Record_ID=skin_irritation_invitro_1537; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (50%); Concentration=50; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiDerm Irritation; Endpoint=ET50; Response=139; Response_Unit=min; Reference=Fentem et al. 2001; 11259870; 10.1016/s0887-2333(01)00002-9; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Positive reaction |
22.5 |
% |
Human |
Dermal |
- |
In Vivo; Four-hour Human Patch Test |
sheet=Data_invivo; excel_row=415; Record_ID=skin_irritation_invivo_59; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=Four-hour Human Patch Test; Endpoint=Positive reaction; Response=22.5; Response_Unit=%; Species=Human; Reference=Robinson et al. 2001; 11422260; 10.1034/j.1600-0536.2001.045001001.x; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Positive reaction |
68.8 |
% |
Human |
Dermal |
- |
In Vivo; Four-hour Human Patch Test |
sheet=Data_invivo; excel_row=416; Record_ID=skin_irritation_invivo_61; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=Four-hour Human Patch Test; Endpoint=Positive reaction; Response=68.8; Response_Unit=%; Species=Human; Reference=Robinson et al. 2001; 11422260; 10.1034/j.1600-0536.2001.045001001.x; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Positive reaction |
70.8 |
% |
Human |
Dermal |
- |
In Vivo; Four-hour Human Patch Test |
sheet=Data_invivo; excel_row=418; Record_ID=skin_irritation_invivo_90; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=Four-hour Human Patch Test; Endpoint=Positive reaction; Response=70.8; Response_Unit=%; Species=Human; Reference=Robinson et al. 2001; 11422260; 10.1034/j.1600-0536.2001.045001001.x; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Positive reaction |
79.7 |
% |
Human |
Dermal |
- |
In Vivo; Four-hour Human Patch Test |
sheet=Data_invivo; excel_row=417; Record_ID=skin_irritation_invivo_89; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=Four-hour Human Patch Test; Endpoint=Positive reaction; Response=79.7; Response_Unit=%; Species=Human; Reference=Jirova et al. 2010; 20136894; 10.1111/j.1600-0536.2009.01640.x; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Positive reaction |
83.1 |
% |
Human |
Dermal |
- |
In Vivo; Four-hour Human Patch Test |
sheet=Data_invivo; excel_row=413; Record_ID=skin_irritation_invivo_88; Data_Type=In Vivo; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=Four-hour Human Patch Test; Endpoint=Positive reaction; Response=83.1; Response_Unit=%; Species=Human; Reference=Basketter et al. 2004; 15291823; 10.1111/j.0105-1873.2004.00385.x; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
TER |
1.4 |
kiloohms |
- |
Dermal |
- |
In Vitro; TER Corrosion |
sheet=Data_invitro; excel_row=1330; Record_ID=skin_irritation_invitro_2552; Data_Type=In Vitro; Formulation_ID=MIX787; Formulation_Name=Empicol LZPV/C; Mixture=Mixture; DTXSID=DTXSID1026031; Assay=TER Corrosion; Endpoint=TER; Response=1.4; Response_Unit=kiloohms; Reference=Botham et al. 1995; Not available; 10.1177/026119299502300207; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
TER |
1.5 |
kiloohms |
- |
Dermal |
- |
In Vitro; TER Corrosion |
sheet=Data_invitro; excel_row=1329; Record_ID=skin_irritation_invitro_2551; Data_Type=In Vitro; Formulation_ID=MIX787; Formulation_Name=Empicol LZPV/C; Mixture=Mixture; DTXSID=DTXSID1026031; Assay=TER Corrosion; Endpoint=TER; Response=1.5; Response_Unit=kiloohms; Reference=Botham et al. 1995; Not available; 10.1177/026119299502300207; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
1.7 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1242; Record_ID=skin_irritation_invitro_727; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=1.7; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
1.8 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1221; Record_ID=skin_irritation_invitro_706; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=1.8; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
2 |
% |
- |
Dermal |
- |
In Vitro; EpiDerm Irritation |
sheet=Data_invitro; excel_row=1284; Record_ID=skin_irritation_invitro_960; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (50%); Concentration=50; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiDerm Irritation; Endpoint=Viability; Response=2; Response_Unit=%; Reference=Zuang et al. 2002; 11827575; 10.1177/026119290203000110; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
2.1 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1190; Record_ID=skin_irritation_invitro_675; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=2.1; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
2.2 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1214; Record_ID=skin_irritation_invitro_699; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=2.20; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
2.3 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1175; Record_ID=skin_irritation_invitro_660; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=2.30; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
2.4 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1205; Record_ID=skin_irritation_invitro_690; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=2.4; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
2.5 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1192; Record_ID=skin_irritation_invitro_677; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=2.5; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
2.6 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1230; Record_ID=skin_irritation_invitro_715; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=2.6; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
2.62 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1186; Record_ID=skin_irritation_invitro_671; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=2.62; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
2.7 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1191; Record_ID=skin_irritation_invitro_676; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=2.7; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
2.8 |
% |
- |
Dermal |
- |
In Vitro; EpiDerm Irritation |
sheet=Data_invitro; excel_row=1285; Record_ID=skin_irritation_invitro_962; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (50%); Concentration=50; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiDerm Irritation; Endpoint=Viability; Response=2.8; Response_Unit=%; Reference=Zuang et al. 2002; 11827575; 10.1177/026119290203000110; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
2.89 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1196; Record_ID=skin_irritation_invitro_681; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=2.89; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
2.9 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1208; Record_ID=skin_irritation_invitro_693; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=2.9; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
2.93 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1199; Record_ID=skin_irritation_invitro_684; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=2.93; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
3.1 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1201; Record_ID=skin_irritation_invitro_686; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=3.1; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
3.2 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1210; Record_ID=skin_irritation_invitro_695; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=3.2; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
3.3 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1171; Record_ID=skin_irritation_invitro_656; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=3.3; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
3.4 |
% |
- |
Dermal |
- |
In Vitro; EpiDerm Irritation |
sheet=Data_invitro; excel_row=1286; Record_ID=skin_irritation_invitro_964; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (50%); Concentration=50; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiDerm Irritation; Endpoint=Viability; Response=3.4; Response_Unit=%; Reference=Zuang et al. 2002; 11827575; 10.1177/026119290203000110; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
3.49 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1180; Record_ID=skin_irritation_invitro_665; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=3.49; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
3.5 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1194; Record_ID=skin_irritation_invitro_679; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=3.5; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
3.51 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1224; Record_ID=skin_irritation_invitro_709; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=3.51; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
3.6 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1216; Record_ID=skin_irritation_invitro_701; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=3.6; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
3.8 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1219; Record_ID=skin_irritation_invitro_704; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=3.8; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
3.94 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1227; Record_ID=skin_irritation_invitro_712; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=3.94; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
3.97 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1228; Record_ID=skin_irritation_invitro_713; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=3.97; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
4.1 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1193; Record_ID=skin_irritation_invitro_678; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=4.10; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
4.2 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1211; Record_ID=skin_irritation_invitro_696; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=4.2; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
4.42 |
% |
- |
Dermal |
- |
In Vitro; EpiSkin Irritation |
sheet=Data_invitro; excel_row=1172; Record_ID=skin_irritation_invitro_657; Data_Type=In Vitro; Formulation_Name=SLS 50% (aq.); Concentration=50; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiSkin Irritation; Endpoint=Viability; Response=4.42; Response_Unit=%; Reference=Cotovio et al. 2005; 16185103; 10.1177/026119290503300403; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
4.46 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1187; Record_ID=skin_irritation_invitro_672; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=4.46; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
4.7 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1251; Record_ID=skin_irritation_invitro_736; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=4.7; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
4.8 |
% |
- |
Dermal |
- |
In Vitro; EpiSkin Irritation |
sheet=Data_invitro; excel_row=1278; Record_ID=skin_irritation_invitro_949; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (50%); Concentration=50; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiSkin Irritation; Endpoint=Viability; Response=4.8; Response_Unit=%; Reference=Fentem et al. 2001; 11259870; 10.1016/s0887-2333(01)00002-9; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
4.81 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1182; Record_ID=skin_irritation_invitro_667; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=4.81; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
5 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1225; Record_ID=skin_irritation_invitro_710; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=5; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
5.2 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1231; Record_ID=skin_irritation_invitro_716; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=5.2; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
5.4 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1240; Record_ID=skin_irritation_invitro_725; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=5.4; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
5.45 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1184; Record_ID=skin_irritation_invitro_669; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=5.45; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
5.6 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1241; Record_ID=skin_irritation_invitro_726; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=5.6; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
5.7 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1234; Record_ID=skin_irritation_invitro_719; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=5.7; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
5.9 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1198; Record_ID=skin_irritation_invitro_683; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=5.9; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
6 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1173; Record_ID=skin_irritation_invitro_658; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=6; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
6.1 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1174; Record_ID=skin_irritation_invitro_659; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=6.1; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
6.35 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1269; Record_ID=skin_irritation_invitro_931; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=6.35; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
6.4 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1223; Record_ID=skin_irritation_invitro_708; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=6.4; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
6.7 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1245; Record_ID=skin_irritation_invitro_730; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=6.7; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
7 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1176; Record_ID=skin_irritation_invitro_661; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=7; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
7.17 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1189; Record_ID=skin_irritation_invitro_674; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=7.17; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
7.22 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1260; Record_ID=skin_irritation_invitro_912; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=7.22; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
7.3 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1178; Record_ID=skin_irritation_invitro_663; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=7.3; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
7.4 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1246; Record_ID=skin_irritation_invitro_731; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=7.4; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
7.5 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1179; Record_ID=skin_irritation_invitro_664; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=7.5; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
7.6 |
% |
- |
Dermal |
- |
In Vitro; EpiSkin Irritation |
sheet=Data_invitro; excel_row=1279; Record_ID=skin_irritation_invitro_951; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (50%); Concentration=50; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiSkin Irritation; Endpoint=Viability; Response=7.6; Response_Unit=%; Reference=Fentem et al. 2001; 11259870; 10.1016/s0887-2333(01)00002-9; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
7.7 |
% |
- |
Dermal |
- |
In Vitro; EpiDerm Irritation |
sheet=Data_invitro; excel_row=1266; Record_ID=skin_irritation_invitro_925; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (20% aq.); Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiDerm Irritation; Endpoint=Viability; Response=7.7; Response_Unit=%; Reference=Kandarova et al. 2005; 16185104; 10.1177/026119290503300408; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
7.8 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1249; Record_ID=skin_irritation_invitro_734; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=7.8; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
8 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1235; Record_ID=skin_irritation_invitro_720; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=8; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
8.1 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1181; Record_ID=skin_irritation_invitro_666; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=8.1; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
8.2 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1207; Record_ID=skin_irritation_invitro_692; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=8.20; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
8.5 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1195; Record_ID=skin_irritation_invitro_680; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=8.5; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
8.8 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1200; Record_ID=skin_irritation_invitro_685; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=8.80; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
9.2 |
% |
- |
Dermal |
- |
In Vitro; EpiSkin Irritation |
sheet=Data_invitro; excel_row=1280; Record_ID=skin_irritation_invitro_953; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (50%); Concentration=50; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiSkin Irritation; Endpoint=Viability; Response=9.20; Response_Unit=%; Reference=Fentem et al. 2001; 11259870; 10.1016/s0887-2333(01)00002-9; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
9.4 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1177; Record_ID=skin_irritation_invitro_662; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=9.4; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
9.6 |
% |
- |
Dermal |
- |
In Vitro; EpiDerm Irritation |
sheet=Data_invitro; excel_row=1263; Record_ID=skin_irritation_invitro_919; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (50%); Concentration=50; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiDerm Irritation; Endpoint=Viability; Response=9.6; Response_Unit=%; Reference=Kandarova et al. 2004; 15329774; Not available|Kandarova et al. 2005; 16185104; 10.1177/026119290503300408; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
9.76 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1275; Record_ID=skin_irritation_invitro_943; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=9.76; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
9.9 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1226; Record_ID=skin_irritation_invitro_711; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=9.9; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
10.2 |
% |
- |
Dermal |
- |
In Vitro; EpiSkin Irritation |
sheet=Data_invitro; excel_row=1183; Record_ID=skin_irritation_invitro_668; Data_Type=In Vitro; Formulation_Name=SLS 20% (aq.); Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiSkin Irritation; Endpoint=Viability; Response=10.20; Response_Unit=%; Reference=Cotovio et al. 2005; 16185103; 10.1177/026119290503300403; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
10.7 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1236; Record_ID=skin_irritation_invitro_721; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=10.7; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
10.8 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1212; Record_ID=skin_irritation_invitro_697; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=10.8; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
10.9 |
% |
- |
Dermal |
- |
In Vitro; EpiSkin Irritation |
sheet=Data_invitro; excel_row=1273; Record_ID=skin_irritation_invitro_939; Data_Type=In Vitro; Formulation_Name=soidum lauryl sulphate (50%); Concentration=50; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiSkin Irritation; Endpoint=Viability; Response=10.9; Response_Unit=%; Reference=Portes et al. 2002; 12423661; 10.1016/s0887-2333(02)00090-5; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
11.7 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1204; Record_ID=skin_irritation_invitro_689; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=11.7; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
11.74 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1261; Record_ID=skin_irritation_invitro_915; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=11.74; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
12 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1248; Record_ID=skin_irritation_invitro_733; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=12; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
12.1 |
% |
- |
Dermal |
- |
In Vitro; EpiSkin Irritation |
sheet=Data_invitro; excel_row=1287; Record_ID=skin_irritation_invitro_966; Data_Type=In Vitro; Formulation_Name=Sodium dodecyl sulfate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiSkin Irritation; Endpoint=Viability; Response=12.1; Response_Unit=%; Reference=Portes et al. 2002; 12423661; 10.1016/s0887-2333(02)00090-5; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
12.2 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1218; Record_ID=skin_irritation_invitro_703; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=12.2; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
12.3 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1250; Record_ID=skin_irritation_invitro_735; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=12.3; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
12.5 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1233; Record_ID=skin_irritation_invitro_718; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=12.5; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
12.6 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1243; Record_ID=skin_irritation_invitro_728; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=12.6; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
12.9 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1247; Record_ID=skin_irritation_invitro_732; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=12.9; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
13 |
% |
- |
Dermal |
- |
In Vitro; EpiSkin Irritation |
sheet=Data_invitro; excel_row=1288; Record_ID=skin_irritation_invitro_968; Data_Type=In Vitro; Formulation_Name=Sodium dodecyl sulfate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiSkin Irritation; Endpoint=Viability; Response=13; Response_Unit=%; Reference=Portes et al. 2002; 12423661; 10.1016/s0887-2333(02)00090-5; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
13.9 |
% |
- |
Dermal |
- |
In Vitro; EpiSkin Irritation |
sheet=Data_invitro; excel_row=1289; Record_ID=skin_irritation_invitro_970; Data_Type=In Vitro; Formulation_Name=Sodium dodecyl sulfate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiSkin Irritation; Endpoint=Viability; Response=13.9; Response_Unit=%; Reference=Portes et al. 2002; 12423661; 10.1016/s0887-2333(02)00090-5; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
14.08 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1262; Record_ID=skin_irritation_invitro_917; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=14.08; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
14.5 |
% |
- |
Dermal |
- |
In Vitro; EpiDerm Irritation |
sheet=Data_invitro; excel_row=1265; Record_ID=skin_irritation_invitro_923; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (50%); Concentration=50; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiDerm Irritation; Endpoint=Viability; Response=14.5; Response_Unit=%; Reference=Kandarova et al. 2004; 15329774; Not available|Kandarova et al. 2005; 16185104; 10.1177/026119290503300408; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
14.7 |
% |
- |
Dermal |
- |
In Vitro; EpiSkin Irritation |
sheet=Data_invitro; excel_row=1282; Record_ID=skin_irritation_invitro_957; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (50%); Concentration=50; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiSkin Irritation; Endpoint=Viability; Response=14.7; Response_Unit=%; Reference=Fentem et al. 2001; 11259870; 10.1016/s0887-2333(01)00002-9; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
15.67 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1270; Record_ID=skin_irritation_invitro_933; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=15.67; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
21.2 |
% |
- |
Dermal |
- |
In Vitro; EpiDerm Irritation |
sheet=Data_invitro; excel_row=1268; Record_ID=skin_irritation_invitro_929; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (20% aq.); Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiDerm Irritation; Endpoint=Viability; Response=21.2; Response_Unit=%; Reference=Kandarova et al. 2005; 16185104; 10.1177/026119290503300408; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
27.55 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1271; Record_ID=skin_irritation_invitro_935; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=27.55; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
31.6 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1276; Record_ID=skin_irritation_invitro_945; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=31.6; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
34 |
% |
- |
Dermal |
- |
In Vitro; EpiSkin Irritation |
sheet=Data_invitro; excel_row=1274; Record_ID=skin_irritation_invitro_941; Data_Type=In Vitro; Formulation_Name=soidum lauryl sulphate (50%); Concentration=50; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiSkin Irritation; Endpoint=Viability; Response=34; Response_Unit=%; Reference=Portes et al. 2002; 12423661; 10.1016/s0887-2333(02)00090-5; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
36.81 |
% |
- |
Dermal |
- |
In Vitro; EpiSkin Irritation |
sheet=Data_invitro; excel_row=1185; Record_ID=skin_irritation_invitro_670; Data_Type=In Vitro; Formulation_Name=SLS 50% (aq.); Concentration=50; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiSkin Irritation; Endpoint=Viability; Response=36.81; Response_Unit=%; Reference=Cotovio et al. 2005; 16185103; 10.1177/026119290503300403; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
38.61 |
% |
- |
Dermal |
- |
In Vitro; LabCyte EPI-MODEL24 Irritation |
sheet=Data_invitro; excel_row=1277; Record_ID=skin_irritation_invitro_947; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (5%); Concentration=5; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte EPI-MODEL24 Irritation; Endpoint=Viability; Response=38.61; Response_Unit=%; Reference=Kojima et al. 2012; 22558976; 10.1177/026119291204000108; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
52 |
% |
- |
Dermal |
- |
In Vitro; EpiSkin Irritation |
sheet=Data_invitro; excel_row=1290; Record_ID=skin_irritation_invitro_972; Data_Type=In Vitro; Formulation_Name=Sodium dodecyl sulfate (1%); Concentration=1; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiSkin Irritation; Endpoint=Viability; Response=52; Response_Unit=%; Reference=Portes et al. 2002; 12423661; 10.1016/s0887-2333(02)00090-5; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
53.1 |
% |
- |
Dermal |
- |
In Vitro; EpiSkin Irritation |
sheet=Data_invitro; excel_row=1291; Record_ID=skin_irritation_invitro_973; Data_Type=In Vitro; Formulation_Name=Sodium dodecyl sulfate (1%); Concentration=1; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiSkin Irritation; Endpoint=Viability; Response=53.1; Response_Unit=%; Reference=Portes et al. 2002; 12423661; 10.1016/s0887-2333(02)00090-5; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
61.32 |
% |
- |
Dermal |
- |
In Vitro; EpiSkin Irritation |
sheet=Data_invitro; excel_row=1188; Record_ID=skin_irritation_invitro_673; Data_Type=In Vitro; Formulation_Name=SLS 20% (aq.); Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiSkin Irritation; Endpoint=Viability; Response=61.32; Response_Unit=%; Reference=Cotovio et al. 2005; 16185103; 10.1177/026119290503300403; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
75.3 |
% |
- |
Dermal |
- |
In Vitro; EpiSkin Irritation |
sheet=Data_invitro; excel_row=1292; Record_ID=skin_irritation_invitro_975; Data_Type=In Vitro; Formulation_Name=Sodium dodecyl sulfate (1%); Concentration=1; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiSkin Irritation; Endpoint=Viability; Response=75.3; Response_Unit=%; Reference=Portes et al. 2002; 12423661; 10.1016/s0887-2333(02)00090-5; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability |
77.1 |
% |
- |
Dermal |
- |
In Vitro; EpiSkin Irritation |
sheet=Data_invitro; excel_row=1283; Record_ID=skin_irritation_invitro_958; Data_Type=In Vitro; Formulation_Name=Sodium lauryl sulphate (50%); Concentration=50; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiSkin Irritation; Endpoint=Viability; Response=77.10; Response_Unit=%; Reference=Fentem et al. 2001; 11259870; 10.1016/s0887-2333(01)00002-9; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (18 hours) |
0.6 |
% |
- |
Dermal |
- |
In Vitro; Vitrolife-Skin Irritation |
sheet=Data_invitro; excel_row=1256; Record_ID=skin_irritation_invitro_761; Data_Type=In Vitro; Concentration=50; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=Vitrolife-Skin Irritation; Endpoint=Viability (18 hours); Response=0.6; Response_Unit=%; Reference=Morikawa et al. 2008; Not available; 10.11232/AATEX.13.11; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (18 hours) |
1.8 |
% |
- |
Dermal |
- |
In Vitro; Vitrolife-Skin Irritation |
sheet=Data_invitro; excel_row=1252; Record_ID=skin_irritation_invitro_760; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=Vitrolife-Skin Irritation; Endpoint=Viability (18 hours); Response=1.8; Response_Unit=%; Reference=Morikawa et al. 2008; Not available; 10.11232/AATEX.13.11; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (240 minutes) |
79 |
% |
- |
Dermal |
- |
In Vitro; EpiSkin Corrosion |
sheet=Data_invitro; excel_row=1326; Record_ID=skin_irritation_invitro_2368; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiSkin Corrosion; Endpoint=Viability (240 minutes); Response=79; Response_Unit=%; Reference=Alepee et al. 2014; 24211528; 10.1016/j.tiv.2013.10.016; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (240 minutes) |
80.6 |
% |
- |
Dermal |
- |
In Vitro; EpiSkin Corrosion |
sheet=Data_invitro; excel_row=1328; Record_ID=skin_irritation_invitro_2372; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiSkin Corrosion; Endpoint=Viability (240 minutes); Response=80.60; Response_Unit=%; Reference=Alepee et al. 2014; 24211528; 10.1016/j.tiv.2013.10.016; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (240 minutes) |
94.2 |
% |
- |
Dermal |
- |
In Vitro; EpiSkin Corrosion |
sheet=Data_invitro; excel_row=1327; Record_ID=skin_irritation_invitro_2370; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiSkin Corrosion; Endpoint=Viability (240 minutes); Response=94.2; Response_Unit=%; Reference=Alepee et al. 2014; 24211528; 10.1016/j.tiv.2013.10.016; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (3 minutes) |
74.1 |
% |
- |
Dermal |
- |
In Vitro; EpiDerm Corrosion |
sheet=Data_invitro; excel_row=1319; Record_ID=skin_irritation_invitro_2356; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiDerm Corrosion; Endpoint=Viability (3 minutes); Response=74.10; Response_Unit=%; Reference=Liebsch et al. 2000; 25419920; 10.1177/026119290002800309; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (3 minutes) |
76.4 |
% |
- |
Dermal |
- |
In Vitro; EpiDerm Corrosion |
sheet=Data_invitro; excel_row=1296; Record_ID=skin_irritation_invitro_2360; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiDerm Corrosion; Endpoint=Viability (3 minutes); Response=76.40; Response_Unit=%; Reference=Liebsch et al. 2000; 25419920; 10.1177/026119290002800309; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (3 minutes) |
80.3 |
% |
- |
Dermal |
- |
In Vitro; EpiDerm Corrosion |
sheet=Data_invitro; excel_row=1322; Record_ID=skin_irritation_invitro_2364; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiDerm Corrosion; Endpoint=Viability (3 minutes); Response=80.3; Response_Unit=%; Reference=Liebsch et al. 2000; 25419920; 10.1177/026119290002800309; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (3 minutes) |
85.2 |
% |
- |
Dermal |
- |
In Vitro; SkinEthic Corrosion |
sheet=Data_invitro; excel_row=1312; Record_ID=skin_irritation_invitro_2336; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=SkinEthic Corrosion; Endpoint=Viability (3 minutes); Response=85.2; Response_Unit=%; Reference=Tornier et al. 2010; 20471469; 10.1016/j.tiv.2010.05.005; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (3 minutes) |
89 |
% |
- |
Dermal |
- |
In Vitro; EpiSkin Corrosion |
sheet=Data_invitro; excel_row=1318; Record_ID=skin_irritation_invitro_2372; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiSkin Corrosion; Endpoint=Viability (3 minutes); Response=89; Response_Unit=%; Reference=Alepee et al. 2014; 24211528; 10.1016/j.tiv.2013.10.016; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (3 minutes) |
89.3 |
% |
- |
Dermal |
- |
In Vitro; EpiDerm Corrosion |
sheet=Data_invitro; excel_row=1321; Record_ID=skin_irritation_invitro_2362; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiDerm Corrosion; Endpoint=Viability (3 minutes); Response=89.3; Response_Unit=%; Reference=Liebsch et al. 2000; 25419920; 10.1177/026119290002800309; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (3 minutes) |
90.6 |
% |
- |
Dermal |
- |
In Vitro; EpiDerm Corrosion |
sheet=Data_invitro; excel_row=1320; Record_ID=skin_irritation_invitro_2358; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiDerm Corrosion; Endpoint=Viability (3 minutes); Response=90.6; Response_Unit=%; Reference=Liebsch et al. 2000; 25419920; 10.1177/026119290002800309; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (3 minutes) |
99.3 |
% |
- |
Dermal |
- |
In Vitro; SkinEthic Corrosion |
sheet=Data_invitro; excel_row=1311; Record_ID=skin_irritation_invitro_2313; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=SkinEthic Corrosion; Endpoint=Viability (3 minutes); Response=99.3; Response_Unit=%; Reference=Kandarova et al. 2006; 16455230; 10.1016/j.tiv.2005.11.008; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (3 minutes) |
99.6 |
% |
- |
Dermal |
- |
In Vitro; SkinEthic Corrosion |
sheet=Data_invitro; excel_row=1310; Record_ID=skin_irritation_invitro_2334; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=SkinEthic Corrosion; Endpoint=Viability (3 minutes); Response=99.6; Response_Unit=%; Reference=Tornier et al. 2010; 20471469; 10.1016/j.tiv.2010.05.005; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (3 minutes) |
102.2 |
% |
- |
Dermal |
- |
In Vitro; SkinEthic Corrosion |
sheet=Data_invitro; excel_row=1314; Record_ID=skin_irritation_invitro_2338; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=SkinEthic Corrosion; Endpoint=Viability (3 minutes); Response=102.2; Response_Unit=%; Reference=Tornier et al. 2010; 20471469; 10.1016/j.tiv.2010.05.005; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (3 minutes) |
104.9 |
% |
- |
Dermal |
- |
In Vitro; EpiSkin Corrosion |
sheet=Data_invitro; excel_row=1316; Record_ID=skin_irritation_invitro_2368; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiSkin Corrosion; Endpoint=Viability (3 minutes); Response=104.9; Response_Unit=%; Reference=Alepee et al. 2014; 24211528; 10.1016/j.tiv.2013.10.016; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (3 minutes) |
109.1 |
% |
- |
Dermal |
- |
In Vitro; LabCyte Corrosion |
sheet=Data_invitro; excel_row=1313; Record_ID=skin_irritation_invitro_2315; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte Corrosion; Endpoint=Viability (3 minutes); Response=109.1; Response_Unit=%; Reference=Katoh et al. 2010; 20519850; 10.2131/jts.35.411; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (3 minutes) |
114 |
% |
- |
Dermal |
- |
In Vitro; EpiSkin Corrosion |
sheet=Data_invitro; excel_row=1317; Record_ID=skin_irritation_invitro_2370; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiSkin Corrosion; Endpoint=Viability (3 minutes); Response=114; Response_Unit=%; Reference=Alepee et al. 2014; 24211528; 10.1016/j.tiv.2013.10.016; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (42 hours) |
0.9 |
% |
- |
Dermal |
- |
In Vitro; Vitrolife-Skin Irritation |
sheet=Data_invitro; excel_row=1258; Record_ID=skin_irritation_invitro_761; Data_Type=In Vitro; Concentration=50; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=Vitrolife-Skin Irritation; Endpoint=Viability (42 hours); Response=0.9; Response_Unit=%; Reference=Morikawa et al. 2008; Not available; 10.11232/AATEX.13.11; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (42 hours) |
1.6 |
% |
- |
Dermal |
- |
In Vitro; Vitrolife-Skin Irritation |
sheet=Data_invitro; excel_row=1254; Record_ID=skin_irritation_invitro_760; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=Vitrolife-Skin Irritation; Endpoint=Viability (42 hours); Response=1.6; Response_Unit=%; Reference=Morikawa et al. 2008; Not available; 10.11232/AATEX.13.11; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (60 minutes) |
20.2 |
% |
- |
Dermal |
- |
In Vitro; EpiDerm Corrosion |
sheet=Data_invitro; excel_row=1343; Record_ID=skin_irritation_invitro_2362; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiDerm Corrosion; Endpoint=Viability (60 minutes); Response=20.2; Response_Unit=%; Reference=Liebsch et al. 2000; 25419920; 10.1177/026119290002800309; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (60 minutes) |
23.3 |
% |
- |
Dermal |
- |
In Vitro; EpiDerm Corrosion |
sheet=Data_invitro; excel_row=1336; Record_ID=skin_irritation_invitro_2358; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiDerm Corrosion; Endpoint=Viability (60 minutes); Response=23.3; Response_Unit=%; Reference=Liebsch et al. 2000; 25419920; 10.1177/026119290002800309; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (60 minutes) |
24.8 |
% |
- |
Dermal |
- |
In Vitro; EpiDerm Corrosion |
sheet=Data_invitro; excel_row=1339; Record_ID=skin_irritation_invitro_2366; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiDerm Corrosion; Endpoint=Viability (60 minutes); Response=24.8; Response_Unit=%; Reference=Liebsch et al. 2000; 25419920; 10.1177/026119290002800309; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (60 minutes) |
27.6 |
% |
- |
Dermal |
- |
In Vitro; EpiDerm Corrosion |
sheet=Data_invitro; excel_row=1337; Record_ID=skin_irritation_invitro_2360; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiDerm Corrosion; Endpoint=Viability (60 minutes); Response=27.6; Response_Unit=%; Reference=Liebsch et al. 2000; 25419920; 10.1177/026119290002800309; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (60 minutes) |
28.6 |
% |
- |
Dermal |
- |
In Vitro; LabCyte Corrosion |
sheet=Data_invitro; excel_row=1324; Record_ID=skin_irritation_invitro_2315; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=LabCyte Corrosion; Endpoint=Viability (60 minutes); Response=28.6; Response_Unit=%; Reference=Katoh et al. 2010; 20519850; 10.2131/jts.35.411; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (60 minutes) |
33.2 |
% |
- |
Dermal |
- |
In Vitro; EpiDerm Corrosion |
sheet=Data_invitro; excel_row=1338; Record_ID=skin_irritation_invitro_2364; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiDerm Corrosion; Endpoint=Viability (60 minutes); Response=33.20; Response_Unit=%; Reference=Liebsch et al. 2000; 25419920; 10.1177/026119290002800309; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (60 minutes) |
34.3 |
% |
- |
Dermal |
- |
In Vitro; SkinEthic Corrosion |
sheet=Data_invitro; excel_row=1334; Record_ID=skin_irritation_invitro_2338; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=SkinEthic Corrosion; Endpoint=Viability (60 minutes); Response=34.30; Response_Unit=%; Reference=Tornier et al. 2010; 20471469; 10.1016/j.tiv.2010.05.005; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (60 minutes) |
85.1 |
% |
- |
Dermal |
- |
In Vitro; SkinEthic Corrosion |
sheet=Data_invitro; excel_row=1333; Record_ID=skin_irritation_invitro_2336; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=SkinEthic Corrosion; Endpoint=Viability (60 minutes); Response=85.1; Response_Unit=%; Reference=Tornier et al. 2010; 20471469; 10.1016/j.tiv.2010.05.005; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (60 minutes) |
90.2 |
% |
- |
Dermal |
- |
In Vitro; EpiSkin Corrosion |
sheet=Data_invitro; excel_row=1342; Record_ID=skin_irritation_invitro_2372; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiSkin Corrosion; Endpoint=Viability (60 minutes); Response=90.2; Response_Unit=%; Reference=Alepee et al. 2014; 24211528; 10.1016/j.tiv.2013.10.016; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (60 minutes) |
92.6 |
% |
- |
Dermal |
- |
In Vitro; SkinEthic Corrosion |
sheet=Data_invitro; excel_row=1323; Record_ID=skin_irritation_invitro_2313; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=SkinEthic Corrosion; Endpoint=Viability (60 minutes); Response=92.6; Response_Unit=%; Reference=Kandarova et al. 2006; 16455230; 10.1016/j.tiv.2005.11.008; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (60 minutes) |
100.1 |
% |
- |
Dermal |
- |
In Vitro; EpiSkin Corrosion |
sheet=Data_invitro; excel_row=1340; Record_ID=skin_irritation_invitro_2368; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiSkin Corrosion; Endpoint=Viability (60 minutes); Response=100.1; Response_Unit=%; Reference=Alepee et al. 2014; 24211528; 10.1016/j.tiv.2013.10.016; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (60 minutes) |
103 |
% |
- |
Dermal |
- |
In Vitro; SkinEthic Corrosion |
sheet=Data_invitro; excel_row=1325; Record_ID=skin_irritation_invitro_2334; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=SkinEthic Corrosion; Endpoint=Viability (60 minutes); Response=103; Response_Unit=%; Reference=Tornier et al. 2010; 20471469; 10.1016/j.tiv.2010.05.005; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |
| NTP ICE skin irritation |
Viability (60 minutes) |
114.6 |
% |
- |
Dermal |
- |
In Vitro; EpiSkin Corrosion |
sheet=Data_invitro; excel_row=1341; Record_ID=skin_irritation_invitro_2370; Data_Type=In Vitro; Concentration=20; Concentration_Units=%; Mixture=Chemical; DTXSID=DTXSID1026031; Assay=EpiSkin Corrosion; Endpoint=Viability (60 minutes); Response=114.6; Response_Unit=%; Reference=Alepee et al. 2014; 24211528; 10.1016/j.tiv.2013.10.016; URL_CompTox=https://comptox.epa.gov/dashboard/chemical/details/DTXSID1026031; URL_CEBS=https://doi.org/10.22427/NTP-DATA-DTXSID1026031 |